U-Chart Analysis:Kringle Pharma,Inc.:4884

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Kringle Pharma,Inc. Go to web site 4884 Medicals 東証グロース September 1, 2000 2020.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Kringle Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kringle Pharma,Inc. Balance Sheet 2024年9月期 Kringle Pharma,Inc. Balance Sheet 2023年9月期 Kringle Pharma,Inc. Balance Sheet 2022年9月期 Kringle Pharma,Inc. Balance Sheet 2021年9月期 Kringle Pharma,Inc. Balance Sheet 2020年9月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2024 September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020
Cash and Cash Equivalents 2,313 2,136 2,756 2,138 2,103
Other Current AssetsHelp 443 481 451 497 247
Tangible Fixed AssetsHelp 0 0 0 0 0
Intangible Fixed AssetHelp 0 0 0 0 0
Investments and OthersHelp 1 1 1 1 1
Total AssetsHelp 2,757 2,619 3,209 2,636 2,350
Total Current LiabilitiesHelp 649 597 420 129 162
Total Long-term LiabilitiesHelp 0 0 0 0 0
Shareholder's EquityHelp 2,108 2,022 2,789 2,506 2,189
Total LiabilitiesHelp 2,757 2,619 3,209 2,636 2,350

Kringle Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kringle Pharma,Inc. Profit and Loss Account 2024年9月期 Kringle Pharma,Inc. Profit and Loss Account 2023年9月期 Kringle Pharma,Inc. Profit and Loss Account 2022年9月期 Kringle Pharma,Inc. Profit and Loss Account 2021年9月期 Kringle Pharma,Inc. Profit and Loss Account 2020年9月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2024 September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020
Amount of Sales 80 69 392 290 468
Total Sales 80 69 392 290 468
Cost of SalesHelp - - 88 72 0
Other Costs and RevenueHelp 836 923 635 519 585
Total CostsHelp 836 923 724 591 585
Net RevenueHelp - - 303 218 468
Earnings Before TaxHelp -755 -853 -330 -300 -116
Net IncomeHelp -756 -854 -332 -301 -118
Net Income -756 -854 -332 -301 -118

Kringle Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kringle Pharma,Inc. Cash Flow Statement 2024年9月期 Kringle Pharma,Inc. Cash Flow Statement 2023年9月期 Kringle Pharma,Inc. Cash Flow Statement 2022年9月期 Kringle Pharma,Inc. Cash Flow Statement 2021年9月期 Kringle Pharma,Inc. Cash Flow Statement 2020年9月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2024 September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020
Operating Cash Flow(OFC)Help -661 -689 16 -561 -146
Investing Cash Flow(ICF)Help -121 -121 -254 -254 -
Financing Cash FlowHelp 838 69 603 596 596
Exchange Difference of Cash and Cash EquivalentsHelp 0 -0 0 254 -
Net Increase and Decrease in Cash and Cash Equivalentsn 56 -741 365 35 1,936

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Kringle Pharma,Inc.

Company where related level is highHelp

Tsubota Laboratory Incorporated
CellSource Co., Ltd.
SANTEN PHARMACEUTICAL CO.,LTD.
TSUMURA & CO.
TORII PHARMACEUTICAL CO.,LTD.
KAINOS Laboratories,Inc.
StemRIM Inc.
ONO PHARMACEUTICAL CO.,LTD.
Medrx Co.,Ltd.
Mochida Pharmaceutical Co.,Ltd.